Roche Add us as a preferred source on Google

X @roche

🔄 Data last refreshed 2 months ago

🤝

Make a deal with Roche

👋 Unclaimed listing — auto-generated from public data; rates are estimates, not set by the creator. 🔒 Paid proposals held safely in escrow — released only when the work's approved.

This is an unclaimed, auto-generated listing. It was built only from Roche’s publicly available X information. Roche has not claimed, verified, or endorsed it, and is not affiliated with, sponsored by, or a partner of SocialDB — no partnership or endorsement is implied, and any prices shown are estimates, not set by the creator.

✓ Is this you? Claim it 🗑 Remove this listing

Followers

237.4K

Posts

14.8K

Following

219

Account age

17 yrs

💰 Suggested sponsorship rate

🎁 Free analysisfor Roche

🕵️Fake Followers CheckReal-audience % & bot risk→ 📊Engagement rateBenchmarked vs. peers→ 💰What they chargeFair sponsored-post price→

Known for

Sleep should be a time of rest, not a time of risk.

"I think predictive technology gives us a lot more than just a safe sleep and better predictions. It also means more quality of life and not using this energy for the diabetes, but actually using it for things that matter to

4.8K views Sleep should be a time of rest, not a time of risk. "I think predictive technology gives us a lot more than just a safe sleep and better predictions. It also means more quality of life and not using this energy for the diabetes, but actually using it for things that matter to

Roche’s sequencing by expansion (SBX) technology is transforming DNA sequencing! By converting nucleotide bases into long molecules before it passes through microscopic pores, it scales up molecular signals into digital data.✨ #Biotech #Innovation

https://t.co/P4NOhxj8Ub

3.8K views Roche’s sequencing by expansion (SBX) technology is transforming DNA sequencing! By converting nucleotide bases into long molecules before it passes through microscopic pores, it scales up molecular signals into digital data.✨ #Biotech #Innovation https://t.co/P4NOhxj8Ub

#MEDIA - Roche’s sequencing platform is now available for research use, capable of same‑day whole genome sequencing in research
workflows, demonstrating end‑to‑end whole‑genome results within hours. https://t.co/xFTCoZwDZr

#Genomics #HumanGenetics #RocheSBX #Innovation #NGS

3.2K views #MEDIA - Roche’s sequencing platform is now available for research use, capable of same‑day whole genome sequencing in research workflows, demonstrating end‑to‑end whole‑genome results within hours. https://t.co/xFTCoZwDZr #Genomics #HumanGenetics #RocheSBX #Innovation #NGS

#MEDIA – We are pleased to share that the CHMP has recommended approval of our continuous delivery treatment for adults with neovascular age-related macular degeneration (#nAMD) - the leading cause of blindness in people over 60. 👉 https://t.co/XQSDUcT8Ji

3.1K views #MEDIA – We are pleased to share that the CHMP has recommended approval of our continuous delivery treatment for adults with neovascular age-related macular degeneration (#nAMD) - the leading cause of blindness in people over 60. 👉 https://t.co/XQSDUcT8Ji

📊 Post performance

📊 Activity & format

Posting cadence

1.3 / week

A lower-frequency account — each post lands with more weight.

Content mix

Mostly images

Recent: 0 video · 16 image · 0 text.

Follower / following

1.1K×

Follows 219 back. A strong ratio — an audience that follows them, not a follow-for-follow network.

Recent posts

View on X ↗

🔥 Top post Sleep should be a time of rest, not a time of risk. "I think predictive technology gives us a lot more than just a safe sleep and better predictions. It also means more quality of life and not using this energy for the diabetes, but actually using it for things that matter to 4.8K❤ 15🔁 7

#MEDIA – At #APVRS2026, we're pleased to share new two-year data for our treatment in patients with PCV, a severe sub-type of nAMD – the leading cause of vision loss in people over 60. https://t.co/9XpS4N4WXT 3K❤ 8

#MEDIA – We are pleased to share that the CHMP has recommended approval of our continuous delivery treatment for adults with neovascular age-related macular degeneration (#nAMD) - the leading cause of blindness in people over 60. 👉 https:/… 3.1K❤ 15🔁 6

Roche’s sequencing by expansion (SBX) technology is transforming DNA sequencing! By converting nucleotide bases into long molecules before it passes through microscopic pores, it scales up molecular signals into digital data.✨ #Biotech #In… 3.8K❤ 16🔁 10

#MEDIA – We are pleased to announce that the U.S. FDA has accepted Roche’s supplemental Biologics License Application, with priority review, in primary #MembranousNephropathy Read more here 👉 https://t.co/tezIhxaMRo $ROG $RHHBY 2.3K❤ 13🔁 3

The first fully automated diagnostic solution to identify the most severe form of viral hepatitis is finally here, helping clinicians address the urgent need for a consistent, widely accessible solution. https://t.co/9XpS4N4WXT $RHHBY $R… 2.3K❤ 15🔁 4

We're at #AAIC26! Come by booth to speak to our team about the latest advancements in Alzheimer’s. We look forward to meeting you! 👋 2.4K❤ 10🔁 5

Just 19 minutes per patient to process. Under 24 hours to results. ⏱️ A new blood test for tuberculosis infection is giving labs the efficiency they need to handle growing global testing demands. Faster testing means we're one step closer … 2.1K❤ 9🔁 3

#MEDIA – We are pleased to share that Roche presents new data in Alzheimer’s disease from across its integrated pharmaceutical and diagnostics portfolio at #AAIC26. Learn more 👉 https://t.co/9XpS4N4WXT 2.2K❤ 20🔁 5

#MEDIA We are pleased to share that our Phase III study in advanced #KRAS G12C-positive #NSCLC met its primary endpoint, demonstrating positive top-line results. Read more here: https://t.co/xFTCoZwDZr 2.3K❤ 21🔁 6

The Bundibugyo virus is a rare and deadly strain of #Ebola that often escapes detection by commonly used frontline tests. That’s why containing outbreaks while providing critical surveillance to monitor any further spread is vital. Our com… 1.8K❤ 9🔁 4

#MEDIA - We are pleased that the US FDA has accepted the supplemental Biologics License Application (sBLA) for our investigational medicine for thyroid eye disease (TED). 👉 https://t.co/yQC1GJva21 2.2K❤ 17🔁 4

💡 Facts

🗓️Joined X in 2009 — 17 years ago.

👁️Averages 2.3K views per post.

📤Posts about 1.3× per week.

💬0.01% engagement rate.

🏅Earned the 100K Followers for passing 100K followers.

🕵️ Fake follower check

Estimated

37/100

Low Credibility score

66%

Mixed Real audience

Medium Fake-follower risk

High Data confidence

Est. 66% real, active audience · Medium fake-follower risk.
Low engagement (~1.0% of followers engage each post) — a sign of an inflated or inactive audience.
Organic base — far more followers than accounts it follows.
Established account (17+ years old).
0.01% engagement — below the ~2.2% typical for this size.

Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.

About

We advance science so that we all have more time with the people we love. Read our community guidelines: http://go.roche.com/CG

📸 Gallery

🔀 Audience overlap

Estimated

Estimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.

Al Arabiya English 18%

ash | not an artist… yet 18%

TFTC 15%

IFC Africa 13%

Audible 12%

Shobha Karandlaje 10%

More like this

ash | not an artist… yet

@venzarii

2.3K Followers

Frequently asked questions

How much does Roche charge for a sponsorship?

Roche hasn't published fixed prices yet. Send a proposal through SocialDB and agree terms directly — your payment is held in escrow until the work is approved.

How do I contact Roche for a brand deal or collaboration?

Send a paid deal or collab request right here on SocialDB — we notify Roche, and once they accept, your payment is held safely in escrow and released when the work is approved. You don't need to track down an email.

How many followers does Roche have?

Roche has 237,371 followers on X.